全球狂犬病兽用疫苗市场规模、份额、趋势和成长分析报告（2026-2034年）

预计兽用狂犬病疫苗市场将从 2025 年的 8.5 亿美元成长到 2034 年的 14.8 亿美元，2026 年至 2034 年的复合年增长率为 6.37%。

随着人们对动物健康和通用感染疾病的认识不断提高，全球兽用狂犬病疫苗市场持续扩大。狂犬病仍然是一种严重的病毒性疾病，主要影响宠物和牲畜，尤其是在发展中地区。各国政府和动物福利组织正在积极推广疫苗接种计划，以控制和根除狂犬病在人类与动物之间的传播。

推动成长要素包括伴侣动物强制疫苗接种法规和全球宠物拥有率的不断提高。牲畜数量的增加和兽医基础设施的改善也促进了市场成长。疫苗配方技术和低温运输配送系统的进步提高了疫苗的可及性和有效性。

全球根除犬类传播狂犬病的努力前景光明。公私合营和国际卫生计画有望提高农村地区和医疗资源匮乏地区的疫苗接种率。持续的研发工作可望开发出更持久、更经济的疫苗，进而提高整体疫苗覆盖率。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球兽用狂犬疫苗市场：依应用领域划分

• 市场分析、洞察与预测
• 伴侣动物
• 家畜
• 野生动物

第五章：全球兽用狂犬疫苗市场：依通路划分

• 市场分析、洞察与预测
• 零售
• 电子商务
• 医院和诊所附设药房

第六章：全球兽用狂犬疫苗市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Boehringer Ingelheim International GmbH
  • Zoetis Services LLC
  • Merck & Co. Inc
  • Elanco
  • BroadChem Philippines Biopharma Corporation
  • Virbac
  • Ceva
  • BiogAfA（C）NesisBagAfA3
  • Indian Immunologicals Ltd

The Rabies Veterinary Vaccines Market size is expected to reach USD 1.48 Billion in 2034 from USD 0.85 Billion (2025) growing at a CAGR of 6.37% during 2026-2034.

The Global Rabies Veterinary Vaccines Market is expanding as awareness about animal health and zoonotic diseases continues to increase. Rabies remains a serious viral disease affecting pets and livestock, especially in developing regions. Governments and animal welfare organizations are promoting vaccination programs to control and eliminate rabies transmission among animals and humans.

Major drivers include mandatory vaccination regulations for companion animals and rising pet ownership worldwide. Increasing livestock populations and initiatives to improve veterinary healthcare infrastructure are also supporting market growth. Advances in vaccine formulations and cold chain distribution systems have improved accessibility and effectiveness.

Future prospects appear promising as global campaigns aim to eliminate dog-mediated rabies. Public-private partnerships and international health programs are expected to strengthen vaccination coverage in rural and underserved areas. Continuous research and development efforts may result in longer-lasting and more cost-effective vaccines, boosting overall adoption rates.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Companion Animals
• Livestock Animals
• Wildlife Animals

By Distribution Channel

• Retail
• E-Commerce
• Hospital/Clinic Pharmacies

COMPANIES PROFILED

• Boehringer Ingelheim International GmbH, Zoetis Services LLC, Merck Co Inc, Elanco, BroadChem Philippines Biopharma Corporation, Virbac, Ceva, BiognesisBag, Indian Immunologicals Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RABIES VETERINARY VACCINES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Livestock Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Wildlife Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RABIES VETERINARY VACCINES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Retail Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. E-Commerce Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hospital/Clinic Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RABIES VETERINARY VACCINES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Application
  • 6.2.2 By Distribution Channel
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Application
  • 6.3.2 By Distribution Channel
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Application
  • 6.4.2 By Distribution Channel
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Application
  • 6.5.2 By Distribution Channel
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Application
  • 6.6.2 By Distribution Channel
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL RABIES VETERINARY VACCINES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Boehringer Ingelheim International GmbH
  • 8.2.2 Zoetis Services LLC
  • 8.2.3 Merck & Co. Inc
  • 8.2.4 Elanco
  • 8.2.5 BroadChem Philippines Biopharma Corporation
  • 8.2.6 Virbac
  • 8.2.7 Ceva
  • 8.2.8 BiogAfA(C)NesisBagAfA3
  • 8.2.9 Indian Immunologicals Ltd